Literature DB >> 25337182

Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis.

Kai Guo1, Zhuoying Wang1.   

Abstract

OBJECTIVE: To evaluate the risk factors influencing the recurrence of papillary thyroid carcinoma.
METHODS: This meta-analysis used MEDLINE (PubMed), EMBASE and CNKI including all cohort studies reporting the risk factors influencing the recurrence after the initial operation on PTC up to February 23, 2014. Software RevMan 5.2 was used for meta-analysis.
RESULTS: Thirteen studies with a total of 7048 patients were included in our meta-analysis. Of all variables, gender, extrathyroid extension, LNM, tumor size, distance metastasis, thyroid surgery types and 131-I given or not were significantly correlated with recurrence, While overall recurrence was similar between the group of ≤ 45 years and > 45 years, multifolicality and solitary. However, when stratified the participants by study location (ie, Asian including China, Korea, Japan, Western country including America, France, Italy, Australia), a statistically significant summary odds ratio for age were found in Western country but none in Asian.
CONCLUSION: The risk factors influencing recurrence includes male, extrathyroid extension, LNM, tumor size more than 2 cm, distance metastasis and subtotal thyroidectomy. However, selection of operation mode should be based on not only the recurrence but the comprehensive consideration of the clinical features.

Entities:  

Keywords:  Papillary thyroid carcinoma; recurrence; risk factors

Mesh:

Year:  2014        PMID: 25337182      PMCID: PMC4203153     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study.

Authors:  Elias E Mazokopakis; Anastasios A Tzortzinis; Elpida I Dalieraki-Ott; Athanasios N Tsartsalis; Periklis K Syros; Christos M Karefilakis; Maria G Papadomanolaki; Ioannis K Starakis
Journal:  Hormones (Athens)       Date:  2010 Oct-Dec       Impact factor: 2.885

2.  [European consensus on the management of patients with differentiated carcinoma of the thyroid from follicular epithelium].

Authors:  F Pacini; M Schlumberger; H Dralle; R Ilisea; Y Smith; V Viersinga
Journal:  Vestn Khir Im I I Grek       Date:  2008

3.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

Authors:  Aleksandra Popadich; Olga Levin; James C Lee; Stephanie Smooke-Praw; Kevin Ro; Maisam Fazel; Asit Arora; Neil S Tolley; Fausto Palazzo; Diana L Learoyd; Stan Sidhu; Leigh Delbridge; Mark Sywak; Michael W Yeh
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

4.  Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

Authors:  Jeffrey Liu; Bhuvanesh Singh; Giovanni Tallini; Diane L Carlson; Nora Katabi; Ashok Shaha; R Michael Tuttle; Ronald A Ghossein
Journal:  Cancer       Date:  2006-09-15       Impact factor: 6.860

5.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

6.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

7.  Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kiyoshi Ichihara; Kanji Kuma
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

8.  Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature.

Authors:  Rogelio Gonzalez-Gonzalez; Ronell Bologna-Molina; Ramón Gil Carreon-Burciaga; Marcelo Gómezpalacio-Gastelum; Nelly Molina-Frechero; Sirced Salazar-Rodríguez
Journal:  ISRN Oncol       Date:  2011-12-06

9.  Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.

Authors:  Jack Bowden; Jayne F Tierney; Andrew J Copas; Sarah Burdett
Journal:  BMC Med Res Methodol       Date:  2011-04-07       Impact factor: 4.615

10.  Detecting, quantifying and adjusting for publication bias in meta-analyses: protocol of a systematic review on methods.

Authors:  Katharina Felicitas Mueller; Joerg J Meerpohl; Matthias Briel; Gerd Antes; Erik von Elm; Britta Lang; Viktoria Gloy; Edith Motschall; Guido Schwarzer; Dirk Bassler
Journal:  Syst Rev       Date:  2013-07-25
View more
  36 in total

1.  Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients.

Authors:  Rajshri M Gartland; Carrie C Lubitz
Journal:  Ann Surg Oncol       Date:  2018-05-31       Impact factor: 5.344

Review 2.  Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis.

Authors:  Huy Gia Vuong; Uyen N P Duong; Thong Quang Pham; Hung Minh Tran; Naoki Oishi; Kunio Mochizuki; Tadao Nakazawa; Lewis Hassell; Ryohei Katoh; Tetsuo Kondo
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

3.  Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.

Authors:  C Y Gui; S L Qiu; Z H Peng; M Wang
Journal:  J Endocrinol Invest       Date:  2017-09-07       Impact factor: 4.256

4.  Sex disparities in thyroid cancer: a SEER population study.

Authors:  Peng Li; Ying Ding; Mengyuan Liu; Wenlong Wang; Xinying Li
Journal:  Gland Surg       Date:  2021-12

5.  Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.

Authors:  Amir Sabet; Ina Binse; Hong Grafe; Samer Ezziddin; Rainer Görges; Thorsten D Poeppel; Andreas Bockisch; Sandra J Rosenbaum-Krumme
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-27       Impact factor: 9.236

6.  Papillary thyroid carcinoma: different clinical behavior among pT3 tumors.

Authors:  Maria Joana Santos; Maria João Bugalho
Journal:  Endocrine       Date:  2016-03-21       Impact factor: 3.633

7.  Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer.

Authors:  Samuel Chan; Katarina Karamali; Anna Kolodziejczyk; Georgios Oikonomou; John Watkinson; Vinidh Paleri; Iain Nixon; Dae Kim
Journal:  Eur Thyroid J       Date:  2020-01-28

8.  Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population.

Authors:  Mariana Bonjiorno Martins; Fernando de Assis Batista; Natassia Elena Bufalo; Karina Colombera Peres; Murilo Meneghetti; Ligia Vera Montali da Assumpção; Laura Sterian Ward
Journal:  Endocrine       Date:  2020-09-09       Impact factor: 3.633

9.  Multi-gene assay and clinical characteristics research in papillary thyroid carcinoma.

Authors:  Chang Deng; Shan Li; Zhixin Yang; Yi Dou; Daixing Hu; Jiang Zhu; Denghui Wang; Xinliang Su
Journal:  Gland Surg       Date:  2021-01

10.  Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 "SLC34A2" in Papillary Thyroid Carcinoma: An Immunohistochemical Study.

Authors:  Sarah Adel Hakim; Rasha Mohamed Abd El Atti; Reham Mohamed Faheim; Hoda Hassan Abou Gabal
Journal:  Anal Cell Pathol (Amst)       Date:  2021-07-14       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.